Revel Health review

Revel Health puts a price on every product before checkout, and that is the main reason to look: sermorelin injection $149 a month, NAD⁺ injection $169, NAD⁺ nasal spray $125, each with board-certified provider review, medication, dispensing supplies, three-to-five-day delivery and unlimited provider messaging inside the figure, and each $50 cheaper on the first monthly order. The refund position is better still — a full refund if you are not approved, which is the fairest answer to the pay-then-be-assessed model this whole category runs on, though the policy's fine print ties it to the order not yet having gone to a pharmacy. Coverage stops at 45 states, and the pharmacy behind its USP-compliance claim is never named.

Revel Health is a telehealth storefront that pairs GLP-1 weight care with a longevity line, organized into Longevity, Weight Loss, Energy & Vitality and Recovery & Performance. Its products are sermorelin injections and a sermorelin oral dissolving tablet, NAD⁺ injections, NAD⁺ nasal spray and an NAD⁺ face cream, glutathione injection, B12 and B12/MIC injections, semaglutide and tirzepatide oral dissolving tablets, and semaglutide and tirzepatide injections. It states clearly on every product page that it is not a pharmacy and that it connects patients with licensed healthcare professionals who determine eligibility, with compounding described as taking place in a USP-certified facility.

Buy-then-be-assessed, but with the money-back valve most competitors omit. You select a care program, complete a medical questionnaire, a board-certified provider reviews it — the site claims review inside the hour — and if a prescription is issued, medication ships discreetly in three to five days. If you are not approved, Revel states a 100% refund and cancels any subscription. That single line resolves the biggest objection to a storefront model where you pay before anyone has looked at your history, and it is worth more than a trust badge. Read the refund policy alongside it, though: it says you may be eligible for a refund if you are not approved and no order has been submitted to a pharmacy, and that once a monthly charge has gone to a pharmacy that billing period is not refundable. What comes with the price is spelled out on each card: board-certified provider review, medication and dispensing supplies, discreet delivery, unlimited provider communication, and the refund guarantee. The gaps are geography and sourcing. Coverage is 45 states, with Alaska, Arkansas, North Carolina, New Jersey and Mississippi excluded — a clear list, which is more than most publish, but a shorter one than the 50-state claims other services make. Compounding is described only as USP-compliant, without any pharmacy being named, no medical director is identified, and the product pages carry member testimonials with star displays, which are not independent evidence. A $50 first-order discount applies automatically at checkout, so budget against the standing rate rather than the first charge.

Published on every product page. The Sermorelin Injection Care Program is $149 a month, and the sermorelin oral dissolving tablet is also $149; the NAD⁺ Injection Care Program is $169, the NAD⁺ Nasal Spray Care Program $125 and the NAD⁺ face cream $89, with glutathione injection at $119 and B12 or B12/MIC at $110. Each is a care program rather than a bare vial: board-certified provider review, the medication, dispensing supplies, three-to-five-day discreet delivery, unlimited provider communication and the refund if you are not approved are all inside the figure, and the price is stated as the same at every dose. Two caveats. The $50-off-first-order promotion applies automatically at checkout, so the first month shows as $99 for sermorelin, $119 for NAD⁺ injections and $75 for the nasal spray — budget against the standing price. And no dose, concentration or vial size is stated beside any of these numbers, so what a program actually contains is undefined; ask before you subscribe, because that is the variable that separates two apparently identical $149 sermorelin plans. GLP-1 pricing is shown up front as well — semaglutide injection from $199 a month and tirzepatide injection from $249, with oral dissolving tablets at $149 and $199 — but those are weight-loss figures and are not a peptide price.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Revel states on each product page that it is not a pharmacy, that a licensed provider reviews your questionnaire and prescribes only if medically appropriate, and that its compounding is done in a USP-certified facility — a claim about a facility standard rather than FDA approval of the product, and one no reader can check while the pharmacy goes unnamed. On the evidence, the longevity line splits three ways. Sermorelin is a GHRH analog that signals your pituitary to release your own growth hormone, which the product page describes accurately; the mechanism is well characterized and the long-term human outcome data behind the recovery, sleep and energy claims remains thin. Injected and intranasal NAD⁺ have no controlled human outcome trials at all — the single human intravenous study was a pharmacokinetic pilot finding infused NAD⁺ clears from plasma quickly — and the NAD⁺ forms with human trial data are the oral precursors NR and NMN, which reliably raise blood NAD⁺: a raised biomarker, not a demonstrated clinical benefit. Injectable glutathione has essentially no controlled human outcome data behind the skin-brightness and detoxification claims. An NAD⁺ face cream is further still from anything the evidence supports. Individual results vary.